Biorelix
New Haven, US
Founders & leadership
BR
Brian R. Dixon, Ph.DExecutive
Board
PC
Philippe ChambonBoard director
RL
Ronald LennoxBoard director
WW
William WieslerBoard director
CM
AD
A. Donny StrosbergBoard director
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 1 round · 2012
▶$2.6MraisedMar 2012 · 8 investors · PharmaceuticalsRule 506(b)
▶$2.6MraisedMar 2012 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Philippe ChambonDirector
- Brian R. Dixon, Ph.DExecutive Officer, Director
- A. Donny StrosbergDirector
- Ronald LennoxExecutive Officer, Director
- William WieslerDirector
- Campbell MurrayDirector
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Biorelix raised?
- Biorelix has disclosed $2.6M raised across 1 round.
- Where is Biorelix headquartered?
- Biorelix is headquartered in New Haven, US.